Connect with us

Technology

The MiCA Crypto Alliance Launches with Hedera, Ripple and Aptos Foundation as founding members

Published

on

Leading blockchain innovators Hedera, Ripple, and Aptos Foundation are joining forces with the technical support from DSF to advance crypto-adoption and regulatory adherence.The alliance will launch standardised templates for sustainability disclosures to help crypto-asset service providers (CASPs) and regulated entities comply with the EU’s Markets in Crypto-Assets (MiCA) regulation.Members of the alliance will benefit from access to exclusive resources and support from industry leaders that will simplify compliance with the new regulatory standards.

LONDON, Sept. 18, 2024 /PRNewswire/ — The DLT Science Foundation (DSF) is proud to support the launch of the MiCA Crypto Alliance, with Hedera, Ripple and Aptos Foundation, as founding members. This groundbreaking association brings together some of the most influential players in the blockchain space, and is aimed at streamlining and enhancing compliance with the Markets in Crypto-Assets (MiCA) regulation, with a view to fostering a sustainable and compliant crypto ecosystem.

The Markets in Crypto-Assets (MiCA) regulation will be fully applicable by the end of this year and has been established by the European Union to provide a comprehensive regulatory framework for the crypto market, ensuring transparency, consumer protection, and market integrity. The cryptocurrency industry is in a state of rapid evolution, as global regulatory bodies recognise the urgent need for a solid framework that addresses the need for transparency, investor protection and cyber security. The MiCA regulation is being introduced at a critical time, providing much-needed clarity for the European market and fostering a more secure and dependable environment for cryptocurrency assets.

In addition to introducing well-publicised governance and transparency obligations, MiCA also introduces stringent sustainability-focused disclosure requirements that mandate Crypto-Asset Service Providers (CASPs), which include centralised exchanges and other regulated entities to share information about the climate impact of their operations, at the same time as promoting uniformity and standardisation. The regulation requires that this climate impact assessment be shared via publicly accessible white papers and website descriptions. However, the absence of an official template or guideline document for these communications risks leaving CASPs, which are subject to the disclosure requirements, potentially facing non-compliance through no fault of their own. The MiCA Crypto Alliance, with the DLT Science Foundation (DSF) as its technical partner, is a member-governed initiative that aims to solve this problem by coordinating compliance efforts among leading blockchain projects, blockchain foundations, and CASPs. By standardising white paper content and sustainability indicators, the MiCA Crypto Alliance seeks to ensure consistency and comparability, ultimately reducing the complexities associated with regulatory compliance.

With over a third of crypto hedge funds expecting increased legal and compliance costs in the near future1, largely due to market volatility and evolving regulatory environments, the MiCA Crypto Alliance encourages blockchain innovators and exchanges to participate in this new initiative aimed at fostering a more standardised and compliant industry that will help reduce these costs, increase transparency and promote uniformity. Members will gain access to shared resources, such as advanced compliance tools, expert advice, and networking opportunities with prominent figures in the industry.

Commenting on the launch of the Alliance, Dr. Paolo Tasca, Founder & Chairman of the DSF, said: “In bringing regulatory clarity to the blockchain sector, MiCA represents a significant step towards mass adoption of digital assets and decentralised technologies. The sustainability disclosure requirements contained within the regulation are designed to drive climate accountability from projects operating within this space and encourage the responsible development of these powerful technologies. In enabling the launch of the MiCA Crypto Alliance, we are committed to setting the standards for compliance with the regulation and providing projects with the tools and knowledge they need to thrive in this new landscape.”

Members of the MiCA Crypto Alliance, including Hedera, Ripple, and Aptos Foundation, will have access to exclusive sustainability indicators and AI-powered white paper generation tools developed and provided by DSF. These resources are designed to help members meet MiCA requirements efficiently and effectively, promoting a high standard of compliance and sustainability within the industry.

Hedera, thanks to its unique consensus algorithm, will contribute its expertise in sustainability metrics, while Ripple’s strong commitment to transparency will help ensure regulatory compliance across the network. Finally, Aptos Foundation brings its experience in furthering blockchain-based security and scalability, further strengthening the alliance’s efforts.

Nilmini Rubin, Chief Policy Officer at Hedera, commented: “Becoming a founding member of the MiCA Crypto Alliance is a strategic move that allows us to collaborate with industry leaders, leveraging our combined expertise to achieve shared objectives. By partnering with other esteemed members, we aim to enhance transparency and establish a cohesive regulatory framework. Our goal is to develop a more efficient, transparent, and well-regulated environment that benefits consumers and the entire industry.”

Lauren Weymouth, Director, University Partnerships at Ripple, said: “Ripple is delighted to become a founding member of the MiCA Crypto Alliance. This is a unique opportunity to promote collaboration between the academic community and leaders in the digital assets space, supporting sustainability best practices and regulatory compliance. This underlines Ripple’s long-standing position as an advocate for industry regulation that protects consumers and provides clarity to enterprise, which is essential for the sustainable development of the crypto sector.”

“Aptos Foundation is honoured to be a founding member of the MiCA Crypto Alliance. In addition to delivering exceptional data and boosting interoperability across ecosystems, we believe that coordinated efforts in standardising disclosure obligations are crucial for the long-term success and credibility of Web3” added Bashar Lazaar, Head of Grants & Ecosystem at Aptos Foundation.

Prof. Dr. Dr. h.c. Roman Beck, member of the Steering Committee, MiCA Alliance and Head of the European Blockchain Center said: “At a time when transparency, compliance, and security are becoming increasingly important in the rapidly evolving blockchain and crypto landscape, the MiCA Crypto Alliance offers a unique opportunity to fill an existing gap to help organisations meet these regulatory requirements. The collaboration between some prominent names in the industry will not only foster trust among regulators and market participants but also pave the way for a more sustainable and scalable future for the industry.”

From today, the MiCA Crypto Alliance welcomes new applicants to join this alliance and partner with other members in their collective ambition to enhance transparency and foster a sustainable development of the crypto industry.

For more information on how to become a member, please visit www.micacryptoalliance.com or contact us at mica@dltscience.org.

About the DLT Science Foundation

The DLT Science Foundation (DSF) is a global leader in P2PFISY. DSF’s initiatives aim to build trust and discover truth within the blockchain industry, supporting the development of transparent and sustainable solutions.

About Hedera 

Governed by a council of the world’s leading institutions, Hedera is a high-performance, secure, and sustainable public, permissioned DLT network. It enables seamless tokenization of real-world and digital assets with unmatched performance, security, and compliance. From regulated security tokens to NFTs, Hedera empowers the efficient creation of diverse asset types by providing enterprises and developers with robust open-source tools to unlock illiquid assets and drive the evolution of financial markets.

For more information, visit www.hedera.com, or follow us on Twitter at @Hedera Admin, Telegram at t.me/hederahashgraph, or Discord at www.hedera.com/discord. The Hedera whitepaper can be found at www.hedera.com/papers.

About Ripple

Ripple is the leading provider of digital asset infrastructure for financial institutions—delivering simple, compliant, reliable software that unlocks efficiencies, reduces friction, and enhances innovation in global finance. Ripple’s solutions leverage the XRP Ledger and its native digital asset, XRP, which was purpose-built to enable fast, low-cost, highly scalable transactions across developer and financial use cases. With a proven track record working with regulators and policymakers around the world, Ripple’s payments, custody and stablecoin solutions are pioneering the digital asset economy—building credibility and trust in enterprise blockchain. Together with customers, partners and the developer community, we are transforming the way the world creates, stores, manages and moves value.

About Aptos Foundation

Aptos Foundation is dedicated to supporting the development of the Aptos protocol, decentralised network and ecosystem and driving engagement with the Aptos ecosystem. By unlocking a blockchain with seamless usability, Aptos Foundation aims to bring the benefits of decentralisation to the masses.

PwC Global Crypto Hedge Fund Report, July 2023

Click on the names for more information on: Hedera, Ripple, and Aptos

 

View original content:https://www.prnewswire.co.uk/news-releases/the-mica-crypto-alliance-launches-with-hedera-ripple-and-aptos-foundation-as-founding-members-302251659.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Marvion Inc. Subsidiary Signs Agreement with Engineering Firm for Construction of New State-of-the-Art Warehouse Facility

Published

on

By

HONG KONG, Nov. 14, 2024 /PRNewswire/ — Marvion Inc. (OTC: MVNC) is pleased to announce that its subsidiary United Warehouse Management Limited has officially signed a quotation agreement with Star Warehouse Engineering Limited for the construction of a new, state-of-the-art warehouse facility. The new warehouse will be strategically located to support the company’s growing logistics and storage operations, underscoring MVNC’s commitment to scaling up its infrastructure to meet the increasing market demand.

The new warehouse will feature two floors, each spanning 18,000 square feet, for a total floor area of 36,000 square feet. This expansion is set to enhance MVNC’s storage capabilities, streamline supply chain efficiency, and optimize logistics operations to better serve its expanding customer base.

Strategic Infrastructure Investment to Drive Long-Term Growth

This significant investment marks a crucial step in MVNC’s long-term strategic plan to solidify its position as a leader in the logistics and storage services sector. The new warehouse will not only bolster the company’s existing storage capacity but also enable the integration of advanced logistics and storage technologies. The facility will be equipped with modern automated systems with artificial intelligence engine to support high-volume inventory management and faster turnaround times, further strengthening MVNC’s competitive advantage in the region.

Commenting on this milestone, Mr. Chan Sze Yu, CEO of Marvion Inc., said:
“This new warehouse is a testament to our commitment to expanding our infrastructure to meet the ever-growing demand in the logistics industry. By investing in this state-of-the-art facility, we are positioning Marvion to better serve our clients and seize emerging opportunities in the market. This project will not only enhance our operational efficiency but also increase our capacity to support strategic partners like FedEx, SF Express, and other key clients.”

Supporting Sustainable Growth in the Asia-Pacific Region

Aligned with MVNC’s sustainability goals, the new facility will incorporate environmentally friendly design elements, such as energy-efficient lighting systems and optimized insulation to reduce energy consumption. These initiatives underscore MVNC’s dedication to promoting sustainable business practices while driving growth.

The construction is scheduled to begin in Q4 2024, with completion expected by the end Q2 2025. The new facility is projected to generate significant operational synergies, contributing to the company’s continued revenue growth and profitability.

About Marvion Inc.

Marvion Inc. (OTC: MVNC) is a leading logistics and warehousing solutions provider based in Hong Kong. The company specializes in offering one-stop transport and storage services to business clients, leveraging advanced digital technologies and efficient inventory management systems.

Company Website: www.unitedksk.com

View original content:https://www.prnewswire.com/news-releases/marvion-inc-subsidiary-signs-agreement-with-engineering-firm-for-construction-of-new-state-of-the-art-warehouse-facility-302305403.html

SOURCE Marvion Inc.

Continue Reading

Technology

American Liver Foundation Hosts the 33rd Annual Irwin M. Arias Symposium

Published

on

By

Virtual and in-person event, Bridging Basic Science and Liver Disease, brings together hundreds of leading biomedical scientists and physicians from across the globe 

FAIRFIELD, N.J., Nov. 14, 2024 /PRNewswire/ — American Liver Foundation is excited to host its 33rd annual Irwin M. Arias Symposium, Bridging Basic Science and Liver Disease, on Wednesday, November 20th from 9AM to 5PM ET. Hundreds of leading biomedical scientists and physicians around the world will come together for this prestigious hybrid, in-person and virtual, one-day event. Each presentation highlights remarkable scientific advances in basic biology and engineering while also providing cutting edge research for a better understanding of liver diseases and the best treatment options available today.

Bridging Basic Science & Liver Disease brings together leading biomedical scientists and physicians from across globe

This informative symposium features 10 unique plenary talks from renowned researchers such as Presidential Medal of Freedom recipient and physician-geneticist Francis S. Collins, MD, PhD, who led the Human Genome Project and discovered the genes causing several genetic diseases. He also served under three Presidents as the Director of the U.S. National Institutes of Health (NIH), the largest supporter of biomedical research in the world. He is currently leading a bold effort to eradicate Hepatitis C throughout the United States. Anne Carpenter, PhD, is the Senior Director of the Imaging Platform and an Institute Scientist at the Broad Institute of MIT and Harvard. She was included on the Top 100 list of AI leaders for her team’s open-source CellProfiler software that is used by thousands of biologists worldwide and their Cell Painting assay that has been adopted throughout the pharma industry to accelerate drug discoveries. There will also be a collection of three-minute ‘MicroTalks’ delivered by trainee scientists.

“This unique one-day annual symposium is a must-attend event for scientists interested in exploring innovative, groundbreaking research conducted in labs and the therapeutic treatments eventually delivered in clinics across the country,” said Lorraine Stiehl, CEO, American Liver Foundation. “Over the past 33 years, research presented at this event has led to many advances in the diagnosis and treatment of virtually all liver diseases in children and adults. Dr. Irwin M. Arias, recognized throughout the world, has devoted his life’s work to advancing liver disease research, treatments and cures and we’re so grateful for his expertise. Liver patients everywhere have benefited from his preeminent work.”

Symposium co-chairs include Sangeeta Bhatia, MD, PhD, John J. and Dorothy Wilson Professor, Electrical Engineering and Computer Science and Institute of Medical Engineering and Science Department at MIT, and Wolfram Goessling, MD, PhD, Chief of Gastroenterology at Massachusetts General Hospital, Director of the Harvard-MIT Health Sciences & Technology at Harvard Medical School and a Professor of Medicine at Harvard Medical School. The overall programming has been designed to honor Dr. Arias’ founding commitment to ‘bridging’ the gap between the academic, industrial, and clinical research communities – even across disciplines.

“The burden of chronic liver diseases affects over 100 million people in the United States alone and is rapidly becoming a public health crisis,” said Dr. Goessling, Chief of Gastroenterology at Massachusetts General Hospital. “Unfortunately, we currently lack effective tools for prevention, diagnosis and treatment for many liver conditions, so it’s vitally important to connect basic science research with the ongoing needs prevalent in many clinics and the Arias Symposium provides this opportunity.”

“Significant gaps remain in the understanding of many liver diseases and the fundamental systems involved in normal and pathological liver function,” said Dr. Bhatia, John J. and Dorothy Wilson Professor at MIT’s Institute of Medical Engineering and Science Department. “This scientific conference bridges basic science and liver disease while also nurturing successful careers in basic and translational liver research. The Arias Symposium allows us all to come together to share our research, encourage new trainees to learn more about liver disease and offers everyone one-day to learn what’s new and engaging in the world of liver research and science.”

The symposium is open to researchers at every stage of their careers, and they are encouraged to share perspectives from their academic, industrial, and clinical research settings. In-person attendees will benefit from a poster session and networking opportunities with plenary speakers and other attendees. Breakfast, lunch, and a networking reception will also be provided to in-person attendees. Registration is free for all trainees (postdocs, fellows, grads, students, undergrads, etc.). Registration is $50 for in-person attendees other than trainees. Virtual attendance is free but does require registration. Register here for this informative event.

This one-day virtual program will include topics such as:  

It’s Time to Eliminate Hepatitis C in the U.S. Francis Collins, MD, PhD – National Institutes of Health (VIRTUAL)Post-Transplant Alloimmune Hepatitis – What do we know and What’s New Udeme Ekong, MD, MPH, FAASLD – Georgetown University Detecting Liver Phenotypes and Toxicity Using Cell Image Data Anne Carpenter, PhD – Broad Institute of MIT and HarvardSpatial Clonal Tracing in Solid Tissues Fernando Camargo, PhD – Massachusetts Institute of TechnologyHolistic Multi-Scale Molecular Imaging of Human Organs Kwanghun Chung, PhD – Boston Children’s HospitalCell Identity Conversion – Liver Regeneration and Cell Therapy Lijian Hui, PhD – Shanghai Institutes for Biological SciencesDeveloping Cirrhosis Therapies: The Three Grand Challenges Quin Wills, MD, PhD – Ochre BioPediatric Liver Tumors: Clinical Context and Opportunities for Collaboration Allison O’Neill, MD – Dana-Farber Cancer InstituteUnderstanding How the Organism Monitors Liver Sufficiency to Properly Time RegenerationKristin Knouse, MD, PhD – Massachusetts Institute of TechnologyCellular and Molecular Drivers of Liver Cancer Response to ImmunotherapyMiriam Merad, MD, PhD – Mount Sinai School of Medicine

For the full agenda, list of speakers, and registration, please visit alfevents.org/ariassymposium.  

In addition to the Arias Symposium, American Liver Foundation offers a research awards program in three categories, Liver Scholar Award, Postdoctoral Research Fellowship Award, and Pilot Research Awards that recently funded eight highly innovative projects into these rare diseases – PSC, AIH and BA. Since 1979, ALF’s research awards program has provided more than $28 million in research funding. Over 850 qualified scientists and physicians have pursued research careers in liver biology, disease and treatment because they received these grants early in their careers. Learn more at liverfoundation.org/research.

About the American Liver Foundation
American Liver Foundation (ALF) is a national community of patients, caregivers and medical professionals dedicated to helping people improve their liver health. Providing guidance and life-saving resources, we are a beacon for the 100 million Americans affected by liver disease. We advocate for patients and families, fund medical research and educate the public about liver wellness and disease prevention. We bring people together through our educational programs and events and create a network of support that lasts a lifetime. ALF is the largest organization focused on all liver diseases and the trusted voice for patients and families living with liver disease. For more information visit www.liverfoundation.org or call: 1 800 GO LIVER (800-465-4837).

Media Contacts:                   
Julie Kimbrough
JKimbrough@liverfoundation.org              
Direct dial: 646-737-9409   
Karla Thomas     
Direct dial: 773.575.9477        

Facebook
X
LinkedIn
YouTube
Instagram

View original content to download multimedia:https://www.prnewswire.com/news-releases/american-liver-foundation-hosts-the-33rd-annual-irwin-m-arias-symposium-302305187.html

SOURCE American Liver Foundation

Continue Reading

Technology

Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science’s Biggest Challenges

Published

on

By

RADNOR, Pa., Nov. 14, 2024 /PRNewswire/ — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced the opening of its new flagship Bridgewater Innovation Center. The state-of-the-art research and development facility, located in Bridgewater, NJ, is part of Avantor’s network of 13 research and innovation centers across the globe.

Avantor’s new Bridgewater Innovation Center spans 60,000 square feet, doubling its previous laboratory and pilot plant capacity. Purpose-designed for collaborative work, the center houses spaces for upstream and downstream process development, dedicated analytical testing labs, and a viral vector laboratory. An expanded pilot plant supports scale-up simulations, enabling rapid customization across the entire bioprocessing workflow.

“Our new Bridgewater Innovation Center is twice the size of our previous facility and adds capacity, talent and capabilities to support the growing demands for monoclonal antibodies, cell and gene therapy and mRNA workflows,” said Michael Stubblefield, President and CEO of Avantor. “Working side-by-side with customers in our network of innovation centers across the globe enables us to power science at every step to deliver life-changing therapies faster, and more cost effectively.”

The Bridgewater Innovation Center allows Avantor to optimize and accelerate biomanufacturing processes at scale; resulting in faster problem solving, streamlined knowledge exchange, and strategic co-innovation. Staffed with Ph.D. scientists, bioengineers, biologists, and process engineers, this center enhances both capacity and expertise to support customers’ needs. The facility also supports Avantor’s sustainability goals, reinforcing the Company’s commitment to environmental responsibility.

For more information about the Bridgewater Innovation Center, visit: https://www.avantorsciences.com/us/en/about/innovation-in-biopharma/avantor-bridgewater-innovation-center

About Avantor
Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedInX (Twitter) and Facebook.

Global Media Contact
Eric Van Zanten
Head of External Communications
Avantor
610-529-6219
Eric.VanZanten@avantorsciences.com

Investor Relations Contact
Christina Jones
Vice President, Investor Relations
Avantor
805-617-5297
Christina.Jones@avantorsciences.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/avantor-opens-new-bridgewater-innovation-center-focused-on-solving-life-sciences-biggest-challenges-302304526.html

SOURCE Avantor and Financial News

Continue Reading

Trending